ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX)

CUSIP: 45256X103

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
1,124,549,707
Total 13F shares
68,558,924
Share change
+6,579,019
Total reported value
$255,147,599
Put/Call ratio
78%
Price per share
$3.72
Number of holders
172
Value change
+$21,750,911
Number of buys
81
Number of sells
68

Quarterly Holders Quick Answers

What is CUSIP 45256X103?
CUSIP 45256X103 identifies IBRX - ImmunityBio, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) as of Q3 2024

As of 30 Sep 2024, ImmunityBio, Inc. - Common Stock, par value $0.0001 per share (IBRX) was held by 172 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 68,558,924 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, GOLDMAN SACHS GROUP INC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and NORTHERN TRUST CORP. This page lists 172 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.